Table 5 Comparison of QoL measures in patients with and without a psychiatric diagnosis at the baseline visit
From: Impact of lipodystrophy on health-related quality of life: the QuaLip study
|  | Diagnosed with a psychiatric disease (n = 18) | No psychiatric diagnosis at the baseline visit (n = 47) | p value |
|---|---|---|---|
Age | 34 (28–42) | 37 (27–51) | 0.304 |
Gender | 0.817 | ||
Female | 15 (83.33%) | 38 (80.85%) | |
Male | 3 (16.67%) | 9 (19.15%) | |
Type of lipodystrophy | 0.099 | ||
CGL | 7 (38.89%) | 9 (19.15%) | |
FPLD | 11 (61.11%) | 29 (61.70%) | |
APL | 0 (0.00%) | 9 (19.15%) | |
SF36_PF | 50.00 (20.00–85.00) | 80.00 (45.00–90.00) | 0.033 |
SF36_RP | 12.50 (00.00–50.00) | 75.00 (00.00–100.00) | 0.015 |
SF36_RE | 00.00 (00.00–33.33) | 66.67 (00.00–100.00) | 0.005 |
SF36_VT | 30.00 (20.00–55.00) | 55.00 (35.00–80.00) | 0.002 |
SF36_MH | 40.00 (24.00–56.00) | 60.00 (48.00–76.00) | 0.003 |
SF36_SF | 43.75 (25.00–62.50) | 75.00 (62.50–87.50) | 0.001 |
SF36_BP | 45.00 (32.50–57.50) | 67.50 (45.00–100.00) | 0.014 |
SF36_GH | 20.00 (10.00–30.00) | 45.00 (30.00–60.00) |  < 0.001 |
Beck Depression Score | 21.50 (14.00–33.00) | 14.00 (6.00–22.00) | 0.009 |
EQ-5D-5L index value | 0.39 (0.17–0.68) | 0.72 (0.33–0.88) | 0.008 |
EQ-5D-5L VAS | 50.00 (40.00–75.00) | 80.00 (60.00–90.00) | 0.004 |
Facit Fatigue Score | 20.50 (16.00–28.00) | 29.00 (22.00–43.00) | 0.012 |